Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast : a randomised controlled trial investigating the <font color="red">effects_2</font> <font color="red">on_1</font> <font color="red">airway_2</font> <font color="red">inflammation_2</font> in asthma . 
<br>
<br> BACKGROUND Few studies have compared <font color="red">treatment_1</font> <font color="red">strategies_1</font> <font color="red">in_1</font> <font color="red">patients_1</font> <font color="red">with_1</font> <font color="red">asthma_1</font> poorly controlled on low dose inhaled corticosteroids , and little is known about the <font color="red">effects_1</font> <font color="red">of_1</font> <font color="red">different_1</font> <font color="red">treatments_1</font> <font color="red">on_1</font> <font color="red">airway_2</font> <font color="red">inflammation_2</font> <font color="red">._2</font> In this double - blind , placebo - controlled , parallel group study , we compared the <font color="red">effects_1</font> <font color="red">of_1</font> <font color="red">salmeterol_1</font> <font color="red">plus_1</font> <font color="red">fluticasone_1</font> <font color="red">propionate_1</font> <font color="red">(_1</font> <font color="red">FP_1</font> <font color="red">)_1</font> <font color="red">(_1</font> <font color="red">Seretide_1</font> <font color="red">;_1</font> <font color="red">SFC_1</font> <font color="red">)_1</font> <font color="red">and_1</font> <font color="red">FP_1</font> <font color="red">plus_1</font> <font color="red">montelukast_1</font> <font color="red">(_1</font> <font color="red">FP_1</font> <font color="red">/_1</font> <font color="red">M_1</font> <font color="red">)_1</font> <font color="red">on_1</font> <font color="red">sputum_3</font> <font color="red">inflammatory_3</font> <font color="red">markers_3</font> <font color="red">,_3</font> <font color="red">airway_3</font> <font color="red">responsiveness_3</font> <font color="red">,_3</font> <font color="red">lung_3</font> <font color="red">function_3</font> <font color="red">,_3</font> <font color="red">and_3</font> <font color="red">symptoms_3</font> <font color="red">in_2</font> <font color="red">adult_2</font> <font color="red">asthmatics_2</font> <font color="red">._2</font> 
<br> METHODS Sixty - six subjects were randomised to SFC or FP / M for 12 weeks . The primary outcome was <font color="red">changes_3</font> <font color="red">in_3</font> <font color="red">neutrophil_4</font> <font color="red">,_4</font> <font color="red">eosinophil_4</font> <font color="red">,_4</font> <font color="red">macrophage_4</font> <font color="red">,_4</font> <font color="red">lymphocyte_4</font> <font color="red">,_4</font> <font color="red">and_4</font> <font color="red">epithelial_4</font> <font color="red">cell_4</font> <font color="red">levels_4</font> <font color="red">in_2</font> <font color="red">induced_2</font> <font color="red">sputum_2</font> <font color="red">._2</font> Additional outcomes included the <font color="red">change_2</font> <font color="red">in_2</font> <font color="red">other_2</font> <font color="red">sputum_4</font> <font color="red">markers_4</font> <font color="red">of_4</font> <font color="red">airway_4</font> <font color="red">inflammation_4</font> <font color="red">,_4</font> <font color="red">airway_4</font> <font color="red">responsiveness_4</font> <font color="red">,_4</font> <font color="red">symptom_4</font> <font color="red">control_4</font> <font color="red">,_4</font> <font color="red">and_4</font> <font color="red">lung_4</font> <font color="red">function_4</font> <font color="red">._4</font> 
<br> RESULTS Both treatments had no significant effect on induced <font color="red">sputum_1</font> <font color="red">inflammatory_1</font> cells , although there was a trend for a <font color="red">reduction_1</font> <font color="red">in_1</font> <font color="red">sputum_4</font> <font color="red">eosinophils_4</font> <font color="red">._4</font> Both treatments significantly improved <font color="red">airway_4</font> <font color="red">responsiveness_4</font> <font color="red">,_4</font> whereas SFC generally led to <font color="red">greater_2</font> <font color="red">improvements_2</font> <font color="red">in_2</font> <font color="red">symptom_5</font> <font color="red">control_5</font> <font color="red">and_5</font> <font color="red">lung_5</font> <font color="red">function_5</font> than FP / M. FP / M led to significantly greater <font color="red">reductions_1</font> <font color="red">in_1</font> <font color="red">sputum_4</font> <font color="red">cysteinyl_4</font> <font color="red">leukotrienes_4</font> <font color="red">than_1</font> <font color="red">SFC_1</font> ( treatment ratio 1.80 ; 95% CI 1.09 , 2.94 ) . 
<br> CONCLUSION Both treatments led to similar <font color="red">control_1</font> <font color="red">of_1</font> <font color="red">eosinophilic_3</font> <font color="red">airway_3</font> <font color="red">inflammation_3</font> <font color="red">,_3</font> although <font color="red">PEF_1</font> <font color="red">and_1</font> <font color="red">symptom_1</font> <font color="red">control_1</font> were better with SFC . STUDY NUMBER : SAM40030 ( SOLTA ) .